A gift of clinical pearls
Refractive Editor Vance Thompson, MD, shared some of the highlights in this issue’s Refractive section.
Browse articles from EyeWorld.org related to refractive surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Refractive Editor Vance Thompson, MD, shared some of the highlights in this issue’s Refractive section.
LASIK was established by the PROWL studies as safe and effective, with a high level of satisfaction, but there are patients who are unhappy with their outcomes, though rarely. Why this happens and how to best manage these patients is what three surgeons shared with EyeWorld.
Luke Rebenitsch, MD, described a case where he initially performed same-day hyperopic LASIK with the KAMRA inlay for distance and presbyopia correction in a 46-year-old patient. Several years later, he elected to implant IOLs once the patient started experiencing a hyperopic shift and lens-associated degradation in vision.
While common, EBMD is often missed, so it’s important to look for it. It can be one of the more frequently diagnosed causes of blurry vision before or after cataract surgery.
The inaugural Lindstrom Symposium was held at the 2021 ASCRS Annual Meeting, with presentations on the topics of cornea, cataract, refractive surgery, glaucoma, and business/industry.
Improvements in IOL technologies have increased interest in refractive lens exchange, and there is more confidence among surgeons in its ability to deliver expected outcomes. Two surgeons shared their experiences in this area.
➤ Full results from Phase 3 study for presbyopia-correcting eye drop ➤ Cells from two donors treat dozens of patients with corneal endothelial disease ➤ Study: Dry eye treatment reduces halos after cataract surgery ➤ NDA accepted for IND application for novel, investigational dry eye drug ➤ Acquisition of ophthalmic drug candidate ➤ ASCRS events
➤ FDA grants IDE for MIGS device to start pivotal trial ➤ Breakthrough therapy designation granted for possible Stargardt treatment ➤ Refractive surgery uptick continues ➤ First patient dosed in trial for light-activated optogenetic monotherapy for RP ➤ Diagnostic device company acquires ophthalmic device manufacturer ➤ Two ophthalmic companies partner ➤ ASCRS news and events
ASCRS Subspecialty Day will take place on Friday, July 23, and will include the ASCRS Refractive Day, ASCRS Cornea Day, and ASCRS Glaucoma Day programs. The chairs of these programs spoke to EyeWorld about what attendees can expect.
Vance Thompson, MD, Refractive editor, discusses highlights of the section and how this issue is “a wonderful invitation to our extended family in ophthalmology and a representation of important topics that will be represented at the Annual Meeting.”